The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Gut microbiome alterations in Alzheimer’s disease
Open accessAbstract
Alzheimer’s disease (AD) is the most common form of dementia. However, the etiopathogenesis of this devastating disease is not fully understood. Recent studies in rodents suggest that alterations in the gut microbiome may contribute to amyloid deposition, yet the microbial communities associated with AD have not been characterized in humans. Towards this end, we characterized the bacterial taxonomic composition of fecal samples from participants with and without a diagnosis of dementia due to AD. Our analyses revealed that the gut microbiome of AD participants has decreased microbial diversity and is compositionally distinct from control age- and sex-matched individuals. We identified phylum- through genus-wide differences in bacterial abundance including decreased Firmicutes, increased Bacteroidetes, and decreased Bifidobacterium in the microbiome of AD participants. Furthermore, we observed correlations between levels of differentially abundant genera and cerebrospinal fluid (CSF) biomarkers of AD. These findings add AD to the growing list of diseases associated with gut microbial alterations, as well as suggest that gut bacterial communities may be a target for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A variety of genetic and environmental factors have been implicated in AD etiopathogenesis, including contributions from gut microbiota [13–15].”
From The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease (2018) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Diseases of cognitive decline, such as Alzheimer's disease and vascular dementia, are associated with aberrant microbial compositions when compared with healthy controls (297).”
From Diet and the Microbiota–Gut–Brain Axis: Sowing the Seeds of Good Mental Health (2021) · cites this paper as [297]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These include reductions in beneficial genera such as Lactobacillus and Bifidobacterium, alongside increases in pro-inflammatory taxa like Enterobacteriaceae64.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [64]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies using 16S rRNA gene sequencing and shotgun metagenomic sequencing have consistently identified significant changes in the gut microbiota composition of individuals with AD.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [64]
Experimental — accuracy not yet measuredIn the citing paper
“Human studies show associations between gut microbiota and neurodegenerative diseases148.”
From Microglia in neurodegeneration (2018) · cites this paper as [148]
In the citing paper
“Human studies comparing the composition of the GM of elderly participants suffering from cognitive impairment with healthy individuals indicate significant changes in GM composition. Specifically, there is an increase in pro-inflammatory taxa and a reduction in anti-inflammatory taxa (104–109).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [105]
In the citing paper
“Within the Firmicutes, the families Ruminococcaceae, Turicibacteraceae, and Clostridiaceae were all less abundant in AD patient (160).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [160]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences
Langille, M. G. I., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes, J. A., Clemente, J. C., Burkepile, D. E., Vega Thurber, R. L., Knight, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2676 · Cited by 9,116
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K., & Schloss, P. D. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.01043-13 · Cited by 7,246
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Cited by
Sorted by citations
Items 301–400 of 1,007
Elangovan, S., Borody, T. J., & Holsinger, R. M. D. (2022) · Cells · doi:10.3390/cells12010119 · Cited by 87
Review of microbiota gut brain axis and innate immunity in inflammatory and infective diseases
Yuan, C., He, Y., Xie, K., Feng, L., Gao, S., & Cai, L. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1282431 · Cited by 87
The Role of Diet and Gut Microbiota in Alzheimer’s Disease
Dissanayaka, D. M. S., Jayasena, V., Rainey‐Smith, S. R., Martins, R. N., & Fernando, W. M. A. D. B. (2024) · Nutrients · doi:10.3390/nu16030412 · Cited by 84
Glymphatic System Pathology and Neuroinflammation as Two Risk Factors of Neurodegeneration
Szlufik, S., Kopeć, K., Szleszkowski, S., & Koziorowski, D. (2024) · Cells · doi:10.3390/cells13030286 · Cited by 84
Liu, G., Chong, H.-X., Chung, F. Y.-L., Li, Y., & Liong, M.-T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134608 · Cited by 83
APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease
Hou, M., Xu, G., Ran, M., Luo, W., & Wang, H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.619051 · Cited by 87
Song, X., Zhao, Z., Zhao, Y., Wang, Z., Wang, C., Yang, G., & Li, S. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2021.1991556 · Cited by 83
Zhang, Y., Shen, Y., Liufu, N., Liu, L., Li, W., Shi, Z., Zheng, H., Mei, X., Chen, C.-Y., Jiang, Z., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02216-7 · Cited by 83
An investigation into physical frailty as a link between the gut microbiome and cognitive health
Verdi, S., Jackson, M. A., Beaumont, M., Bowyer, R. C. E., Bell, J. T., Spector, T. D., & Steves, C. J. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00398 · Cited by 82
Dietary Protein and Amino Acid Intake: Links to the Maintenance of Cognitive Health
Glenn, J. M., Madero, E. N., & Bott, N. (2019) · Nutrients · doi:10.3390/nu11061315 · Cited by 82
Gut Microbiota: Implications in Alzheimer’s Disease
He, Y., Li, B., Sun, D., & Chen, S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072042 · Cited by 82
The interaction of Akkermansia muciniphila with host-derived substances, bacteria and diets
Hagi, T., & Belzer, C. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11362-3 · Cited by 82
Gu, X., Zhou, J., Zhou, Y., Wang, H., Si, N., Ren, W., Zhao, W., Fan, X., Gao, W., Wei, X., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00779-7 · Cited by 81
Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelits (CFS/ME)
Lupo, G. F. D., Rocchetti, G., Lucini, L., Lorusso, L., Manara, E., Bertelli, M., Puglisi, E., & Capelli, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-86425-6 · Cited by 81
Padhi, P., Worth, C., Zenitsky, G. D., Jin, H., Sambamurti, K., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.836605 · Cited by 84
Peng, W., Yi, P., Yang, J., Xu, P., Wang, Y., Zhang, Z., Huang, S., Wang, Z., & Zhang, C. (2018) · Aging · doi:10.18632/aging.101693 · Cited by 81
The intestinal microbiome and its relevance for functionality in older persons
Ticinesi, A., Tana, C., & Nouvenne, A. (2019) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000521 · Cited by 80
Re-thinking the Etiological Framework of Neurodegeneration
Castillo, X., Castro‐Obregón, S., Gutiérrez-Becker, B., Gutiérrez‐Ospina, G., Karalis, N., Khalil, A. A., López‐Noguerola, J. S., Rodríguez, L. L., Martínez‐Martínez, E., Perez‐Cruz, C., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00728 · Cited by 80
How microbiota shape microglial phenotypes and epigenetics
Erny, D., & Prinz, M. (2020) · Glia · doi:10.1002/glia.23822 · Cited by 80
Hole, K. L., & Williams, R. J. (2020) · Brain Plasticity · doi:10.3233/bpl-200098 · Cited by 81
Probiotics: Protecting Our Health from the Gut
Varela-Trinidad, G. U., Domínguez-Díaz, C., Solórzano-Castanedo, K., Íñiguez-Gutiérrez, L., Hernández-Flores, T. D. J., & Fafutis‐Morris, M. (2022) · Microorganisms · doi:10.3390/microorganisms10071428 · Cited by 80
Ağagündüz, D., Bingöl, F. G., Çelik, E., Cemali, Ö., Özenir, Ç., Özoğul, F., & Capasso, R. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03609-y · Cited by 80
The gut microbiota and aging: interactions, implications, and interventions
Gyriki, D., Nikolaidis, C. G., Bezirtzoglou, E., Voidarou, C. C., Stavropoulou, E., & Tsigalou, C. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1452917 · Cited by 80
Syeda, T., Sánchez‐Tapia, M., Pinedo‐Vargas, L., Granados, O., Cuervo-Zanatta, D., Rojas-Santiago, E., Díaz-Cintra, S. Y., Torres, N., & Perez‐Cruz, C. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180556 · Cited by 80
Jones, J. D., Rahmani, E., Garcia, E., & Jacobs, J. P. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.01.009 · Cited by 79
Review: The Role of Intestinal Dysbiosis in Parkinson’s Disease
Huang, Y., Liao, J., Liu, X., Zhong, Y., Cai, X., & Long, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.615075 · Cited by 79
Kim, H., Su-Min, K., Park, S.-J., Park, G., Shin, H., Park, M. S., & Kim, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.709091 · Cited by 79
Liu, P., Gao, M., Liu, Z., Zhang, Y., Tu, H., Lei, L., Wu, P., Zhang, A., Yang, C., Li, G., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.800764 · Cited by 79
Zhou, Y., Xie, L., Schröder, J., Schuster, I. S., Nakai, M. E., Sun, G., Sun, Y., Mariño, E., Degli‐Esposti, M. A., Marques, F. Z., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0724-23.2023 · Cited by 80
Altered gut microbiota in adults with subjective cognitive decline: the SILCODE study
Sheng, C., Lin, L., Lin, H., Wang, X., Han, Y., & Liu, S.-L. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210259 · Cited by 78
Koszewicz, M. A., Jaroch, J., Brzecka, A., Ejma, M., Budrewicz, S. P., Михалева, Л. М., Muresanu, C., Schield, P., Somasundaram, S. G., Kirkland, C. E., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105277 · Cited by 82
Ticinesi, A., Guerra, A., Nouvenne, A., Meschi, T., & Maggi, S. (2023) · Nutrients · doi:10.3390/nu15051138 · Cited by 78
A perspective on green, blue, and grey spaces, biodiversity, microbiota, and human health
Potter, J. D., Brooks, C., Donovan, G. H., Cunningham, C. W., & Douwes, J. E. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.164772 · Cited by 78
Kim, N. Y., Lee, H. Y., Choi, Y. Y., Mo, S. J., Jeon, S., Ha, J. H., Park, S. D., Shim, J.-J., Lee, J., & Chung, B. G. (2024) · Nano Convergence · doi:10.1186/s40580-024-00413-w · Cited by 81
The intestinal microbiome and Alzheimer's disease: A review
Li, Z., Zhu, H., Zhang, L., & Qin, C. (2018) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12033 · Cited by 78
Kaur, H., Golovko, S. A., Golovko, M. Y., Singh, S., Darland, D. C., & Combs, C. K. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200436 · Cited by 78
Danger-Sensing/Patten Recognition Receptors and Neuroinflammation in Alzheimer’s Disease
Chiarini, A., Armato, U., Hu, P., & Prà, I. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239036 · Cited by 77
Cao, J., Amakye, W. K., Qi, C., Liu, X., Ma, J., & Ren, J. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02543-x · Cited by 76
Liang, L., Saunders, C., & Sanossian, N. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3229 · Cited by 79
Wasén, C., Beauchamp, L. C., Vincentini, J., Li, S., LeServe, D. S., Gauthier, C. D., Lopes, J. R., Moreira, T. G., Ekwudo, M. N., Yin, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47683-w · Cited by 77
The virtuous cycle of human genetics and mouse models in drug discovery
Nadeau, J. H., & Auwerx, J. H. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0009-9 · Cited by 78
Welcome, M. O. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08547-5 · Cited by 77
Olfactory dysfunction in the pathophysiological continuum of dementia
Bathini, P., Brai, E., & Auber, L. A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100956 · Cited by 77
Establishment of the early-life microbiome: a DOHaD perspective
Stinson, L. F. (2019) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174419000588 · Cited by 77
Propionate and Alzheimer’s Disease
Killingsworth, J., Sawmiller, D. R., & Shytle, R. D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.580001 · Cited by 76
Alzheimer’s Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical Models
Carranza-Naval, M. J., Vargas-Soria, M., Hierro‐Bujalance, C., Baena‐Nieto, G., García-Alloza, M., Infante‐Garcia, C., & del Marco, À. (2021) · Biomolecules · doi:10.3390/biom11020262 · Cited by 77
Qu, C. F., Li, Q., Su, Z., Ip, S., Yuan, Q., Xie, Y., Xu, Q., Yang, W., Huang, Y., Xian, Y., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.03.012 · Cited by 76
Zou, B., Li, J., Ma, R., Cheng, X.-Y., Ma, R.-Y., Zhou, T.-Y., Wu, Z., Yao, Y., & Li, J. (2023) · Aging and Disease · doi:10.14336/ad.2022.1127 · Cited by 76
Gut Microbiota and its Metabolites: Bridge of Dietary Nutrients and Alzheimer’s Disease
Zhu, G., Zhao, J., Zhang, H., Wang, G., & Chen, W. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.04.005 · Cited by 78
El Dib, R., Periyasamy, A. G., de Barros, J. L., França, C. G., Senefonte, F. L., Vesentini, G., Alves, M. G. O., Rodrigues, J. V. D. S., Gomaa, H., Gomes Júnior, J. R., et al. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.07.027 · Cited by 75
Gut microbiota regulate cognitive deficits and amyloid deposition in a model of Alzheimer’s disease
Li, Z., Zhu, H., Guo, Y., Du, X., & Qin, C. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15031 · Cited by 76
Lim, J.-M., Letchumanan, V., Tan, L. T., Hong, K., Wong, S. H., Mutalib, N. A., Lee, L., & Law, J. W. (2022) · Nutrients · doi:10.3390/nu14173566 · Cited by 75
Yuan, S., Yang, J., Jian, Y., Lei, Y., Yao, S., Hu, Z., Liu, X., Tang, C., & Liu, W. (2022) · Nutrients · doi:10.3390/nu14194134 · Cited by 76
Guzzardi, M. A., Ederveen, T. H. A., Rizzo, F. M., Weisz, A., Collado, M. C., Muratori, F., Gross, G., Alkema, W. B. L., & Iozzo, P. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.12.009 · Cited by 74
Microbiota-Gut-Brain Axis Regulation of Adult Hippocampal Neurogenesis
Guzzetta, K. E., Cryan, J. F., & O’Leary, O. F. (2022) · Brain Plasticity · doi:10.3233/bpl-220141 · Cited by 74
Neuroimmune contributions to Alzheimer’s disease: a focus on human data
Haage, V., & De Jager, P. L. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01637-0 · Cited by 74
Sustainability of the Dairy Industry: Emissions and Mitigation Opportunities
Peterson, C. B., & Mitloehner, F. M. (2021) · Frontiers in Animal Science · doi:10.3389/fanim.2021.760310 · Cited by 73
Impact of the mother's gut microbiota on infant microbiome and brain development
Mady, E. A., Doghish, A. S., El‐Dakroury, W. A., Elkhawaga, S. Y., Ismail, A., El‐Mahdy, H. A., Elsakka, E. G. E., & El‐Husseiny, H. M. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105195 · Cited by 73
Tibbs, T., Lopez, L. R., & Arthur, J. C. (2019) · Microbial Cell · doi:10.15698/mic2019.08.685 · Cited by 74
van der Lugt, B., Rusli, F., Lute, C., Lamprakis, A., Salazar, E., Boekschoten, M. V., Hooiveld, G. J., Müller, M., Vervoort, J., Kersten, S., et al. (2018) · Aging · doi:10.18632/aging.101439 · Cited by 72
Fecal Fungal Dysbiosis in Chinese Patients With Alzheimer’s Disease
Ling, Z., Zhu, M., Liu, X., Shao, L., Cheng, Y., Yan, X., Jiang, R., & Wu, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.631460 · Cited by 72
Bile acid receptors and signaling crosstalk in the liver, gut and brain
Ferrell, J. M., & Chiang, J. Y. L. (2021) · Liver Research · doi:10.1016/j.livres.2021.07.002 · Cited by 72
Kim, G. H., Lee, Y. C., Kim, T. J., Kim, E. R., Hong, S. N., Chang, D. K., & Kim, Y. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab162 · Cited by 72
Jatrorrhizine: A Review of Sources, Pharmacology, Pharmacokinetics and Toxicity
Zhong, F., Chen, Y., Chen, J., Liao, H., Li, Y., & Ma, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.783127 · Cited by 72
Neuroinflammation in neurodegeneration via microbial infections
Tran, V. T. A., Lee, L. P., & Cho, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.907804 · Cited by 72
Xu, Q., Su, Z., Yang, W., Zhong, M., Xian, Y., & Lin, Z. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02704-1 · Cited by 72
The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease
Ocansey, D. K. W., Hang, S., Yuan, X., Qian, H., Zhou, M., Olovo, C. V., Zhang, X., & Mao, F. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2176118 · Cited by 71
Luo, Y., Yang, L.-L., & Yao, X. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00720-0 · Cited by 75
Liang, Y., Liu, C., Cheng, M., Geng, L., Li, J., Du, W., Song, M., Chen, N., Yeleen, T. A. N., Li, S., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14057 · Cited by 73
The Role of P2X7 Receptor in Alzheimer’s Disease
Francistiová, L., Bianchi, C., Lauro, C. D., Sebastián‐Serrano, Á., de Diego-García, L., Kobolák, J., Dinnyés, A., & Díaz-Hernández, M. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00094 · Cited by 73
Bacterially produced metabolites protect C. elegans neurons from degeneration
Urrutia, A., García-Angulo, V. A., Fuentes, A., Caneo, M., Legüe, M., Urquiza, S., Delgado, S. E., Ugalde, J., Burdisso, P., & Calixto, A. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000638 · Cited by 71
Microbiota‐microglia connections in age‐related cognition decline
Zhou, R., Qian, S., Cho, W. C. S., Zhou, J., Jin, C., Zhong, Y., Wang, J., Zhang, X., Xu, Z., Tian, M., et al. (2022) · Aging Cell · doi:10.1111/acel.13599 · Cited by 71
Perioperative neurocognitive dysfunction: thinking from the gut?
Xu, X., Hu, Y., Yan, E., Zhan, G., Liu, C., & Yang, C. (2020) · Aging · doi:10.18632/aging.103738 · Cited by 71
Modulation of Glial Function in Health, Aging, and Neurodegenerative Disease
Hanslik, K. L., Marino, K. M., & Ulland, T. K. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.718324 · Cited by 69
Alteration of Gut Microbiota in Alzheimer’s Disease and Their Relation to the Cognitive Impairment
Khedr, E. M., Omeran, N., Ramadan, H. K., Ahmed, G. K., & Abdelwarith, A. M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220176 · Cited by 73
Liu, X., Liu, Y., Liu, J., Zhang, H., Shan, C., Guo, Y., Gong, X., Cui, M., Li, X., & Tang, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382223 · Cited by 75
Integrating Systems and Synthetic Biology to Understand and Engineer Microbiomes
Leggieri, P. A., Liu, Y., Hayes, M. M., Connors, B., Seppälä, S., O’Malley, M., & Venturelli, O. S. (2021) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-082120-022836 · Cited by 70
Cheng, W., Ho, J. Y. S., & Chang, R. C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101620 · Cited by 71
Qiao, L., Chen, Y., Song, X., Dou, X., & Xu, C. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s374024 · Cited by 70
Interactions between gut microbes and NLRP3 inflammasome in the gut-brain axis
Ding, Y., Wang, Z., Chen, Y., Guo, Q., & Dong, Y. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.03.017 · Cited by 69
Gut microbiota bridges the iron homeostasis and host health
Xiao, L., Tang, R., Wang, J., Wan, D., Yin, Y., & Xie, L. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2302-5 · Cited by 70
Romano, S., Wirbel, J., Ansorge, R., Schudoma, C., Ducarmon, Q. R., Narbad, A., & Zeller, G. (2025) · Nature Communications · doi:10.1038/s41467-025-56829-3 · Cited by 70
Lv, M., Yang, S., Cai, L., Qin, L., Li, B., & Wan, Z. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800621 · Cited by 70
Microbiota-gut-brain axis in the Alzheimer's disease pathology - an overview
Giridharan, V. V., Quevedo, C. E. B. D., & Petronilho, F. C. (2022) · Neuroscience Research · doi:10.1016/j.neures.2022.05.003 · Cited by 69
Gut inflammation associated with age and Alzheimer’s disease pathology: a human cohort study
Heston, M. B., Hanslik, K. L., Zarbock, K. R., Harding, S. J., Davenport‐Sis, N. J., Kerby, R. L., Chin, N. A., Sun, Y., Hoeft, A., Deming, Y. K., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-45929-z · Cited by 69
Self-citationTryptophan metabolites modify brain Aβ peptide degradation: A role in Alzheimer’s disease?
Maître, M., Klein, C., Patte‐Mensah, C., & Mensah‐Nyagan, A. G. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101800 · Cited by 69
Lei, W., Cheng, Y., Liu, X., Gao, J., Zhu, Z., Ding, W., Xu, X., Li, Y., Ling, Z., Jiang, R., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1582119 · Cited by 68
Faith, D. P. (2018) · Springer eBooks · doi:10.1007/978-3-319-93145-6_1 · Cited by 68
Liu, J., Yu, C., Li, R., Liu, K., Jin, G., Ge, R., Tang, F., & Cui, S. (2020) · Food & Function · doi:10.1039/c9fo03007g · Cited by 68
Go, J., Chang, D., Ryu, Y., Park, H., Lee, I.-B., Noh, J., Hwang, D. Y., Kim, B., Kim, K., & Lee, C. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.12.010 · Cited by 69
Contribution of Gut Microbiota to Immunological Changes in Alzheimer’s Disease
van Olst, L., Roks, S. J. M., Kamermans, A., Verhaar, B. J. H., van der Geest, A. M., Muller, M., van der Flier, W. M., & de Vries, H. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683068 · Cited by 68
Białecka-Dębek, A., Granda, D., Szmidt, M. K., & Zielińska, D. (2021) · Nutrients · doi:10.3390/nu13082514 · Cited by 69
Memorable Food: Fighting Age-Related Neurodegeneration by Precision Nutrition
Milošević, M. S., Arsić, A., Cvetković, Z., & Vučić, V. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.688086 · Cited by 68
Park, S.-H., Lee, J. H., Kim, J., Kim, T. J., Shin, J., Im, J. H., Cha, B., Lee, S., Kwon, K. S., Shin, Y. W., et al. (2022) · Aging · doi:10.18632/aging.204230 · Cited by 67
Metformin, Cognitive Function, and Changes in the Gut Microbiome
Rosell-Díaz, M., & Fernández‐Real, J. M. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad029 · Cited by 68
Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
Brown, M. R., Radford, S. E., & Hewitt, E. W. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.609073 · Cited by 67
Jayatunga, D. P. W., Hone, E., Khaira, H., Lunelli, T., Singh, H., Guillemin, G. J., Fernando, B., Garg, M. L., Verdile, G., & Martins, R. N. (2021) · Nutrients · doi:10.3390/nu13113744 · Cited by 67
Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease
Sun, P., Su, L., Zhu, H., Li, X., Guo, Y., Du, X., Zhang, L., & Qin, C. (2021) · Microorganisms · doi:10.3390/microorganisms9112281 · Cited by 68
Dissecting the complexities of Alzheimer disease with in vitro models of the human brain
Blanchard, J., Victor, M. B., & Tsai, L. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00578-6 · Cited by 68
Chen, L., Xu, X., Wu, X., Cao, H., Li, X., Hou, Z., Wang, B., Liu, J., Ji, X., Zhang, P., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.942460 · Cited by 67
Metadata
- Authors
- Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., Carlsson, C. M., Asthana, S., Zetterberg, H., Blennow, K., Bendlin, B. B., & Rey, F. E.
- Affiliations
- University of Wisconsin–Madison (US)
- Sahlgrenska University Hospital (SE)
- Corresponding author
- Bendlin, Barbara B.
- Rey, Federico E.
- ORCID
- Venue
- Scientific Reports
- Published
- 2017-10-19
- Volume
- 7
- Issue
- 1
- Pages
- 13537-13537
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5648830
- OpenAlex
- W2761210275
- Cited by
- 2,137
- References
- 83
- Citations by year
- 2026: 205 · 2025: 322 · 2024: 328 · 2023: 269 · 2022: 339 · 2021: 283 · 2020: 205 · 2019: 119 · 2018: 64 · 2017: 1
- FWCI
- 43.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Alzheimer's Association (R01 AG027161, R01 AG037639, R01 AG021155)
- Torsten Söderbergs Stiftelse
- Rush University
- Georgia Clinical and Translational Science Alliance (UL1TR000427)
- Royal Swedish Academy of Sciences
- Vetenskapsrådet
- National Institutes of Health (UL1TR000427, NIH P50, AG027161, AG037639, NIH P50 AG033514, AG033514)
- Institute for Clinical and Translational Research, University of Wisconsin, Madison (UL1TR000427)
- National Institute on Aging (RF1AG027161, R01AG037639, P50AG033514, R01AG021155, R01AG027161, R56AG037639)
- National Institute of General Medical Sciences (T32GM008692)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, gut microbiota, dementia, fecal microbiota, microbial diversity, Firmicutes, Bacteroidetes, Bifidobacterium, cerebrospinal fluid biomarkers, amyloid deposition, gut-brain axis, therapeutic target
- MeSH terms
- Bacillota, Gastrointestinal Microbiome, Aged, Alzheimer Disease, Bifidobacterium, Feces, Female, Humans, Male, Biomarkers, Case-Control Studies, tau Proteins, Bacteroidetes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
